These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study. Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512 [TBL] [Abstract][Full Text] [Related]
25. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia. Jeske WP; Walenga JM Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410 [TBL] [Abstract][Full Text] [Related]
26. Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin? Seybert AL; Coons JC; Zerumsky K Pharmacotherapy; 2006 Feb; 26(2):229-41. PubMed ID: 16466327 [TBL] [Abstract][Full Text] [Related]
27. Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database. Moffett BS; Teruya J Arch Pathol Lab Med; 2014 Sep; 138(9):1229-32. PubMed ID: 25171706 [TBL] [Abstract][Full Text] [Related]
29. Safety and effectiveness outcomes of an inpatient collaborative drug therapy management service for direct thrombin inhibitors. Cooper T; White CL; Taber D; Uber WE; Kokko H; Mazur J Am J Health Syst Pharm; 2012 Nov; 69(22):1993-8. PubMed ID: 23135566 [TBL] [Abstract][Full Text] [Related]
30. Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol. Smythe MA; Mehta TP; Koerber JM; Forsyth LL; Sykes E; Corbets LR; Melendy SM; Parikh R Am J Health Syst Pharm; 2012 Feb; 69(3):241-8. PubMed ID: 22261947 [TBL] [Abstract][Full Text] [Related]
31. Monitoring of Argatroban and Lepirudin: What is the Input of Laboratory Values in "Real Life"? Seidel H; Kolde HJ Clin Appl Thromb Hemost; 2018 Mar; 24(2):287-294. PubMed ID: 28320219 [TBL] [Abstract][Full Text] [Related]
32. Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis. Sun Z; Lan X; Li S; Zhao H; Tang Z; Xi Y Int J Hematol; 2017 Oct; 106(4):476-483. PubMed ID: 28600720 [TBL] [Abstract][Full Text] [Related]
33. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis. Frame JN; Rice L; Bartholomew JR; Whelton A Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232 [TBL] [Abstract][Full Text] [Related]